BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Quantitative Lipid Peroxidation Detection

Executive Summary: BODIPY 581/591 C11 (SKU C8003) is a cell-permeable, ratiometric fluorescent probe for precise quantification of lipid peroxidation in biological membranes and live cells (APExBIO product page). It produces a quantifiable red-to-green emission shift upon oxidation by reactive oxygen species (ROS), but remains insensitive to superoxide, nitric oxide, or hydrogen peroxide. The probe is highly photostable, maintains a high quantum yield, and is validated for use in oxidative stress measurement and antioxidant capacity evaluation (Zhang et al., 2025). BODIPY 581/591 C11 is widely used in research on ferroptosis, cancer, and neurodegenerative disease models, and is supplied as a solid for optimal stability (MoleculeProbe Guide).

Biological Rationale

Lipid peroxidation is a hallmark of oxidative stress and cell damage, implicated in ferroptosis, neurodegeneration, and cancer progression (Zhang et al., 2025). Accurate detection of lipid peroxidation is essential for elucidating ROS signaling pathways and evaluating antioxidant interventions. Traditional assays lack specificity or ratiometric quantification. BODIPY 581/591 C11 addresses these gaps as a ratiometric fluorescent lipid peroxidation probe, enabling real-time, quantitative monitoring of membrane oxidative stress in live-cell and model membrane systems (apexapoptosis.com). This probe is particularly relevant for research in ferroptosis, where lipid ROS-driven cell death is central, and in studies of antioxidant capacity in disease models.

Mechanism of Action of BODIPY 581/591 C11

BODIPY 581/591 C11 is a synthetic boron-dipyrromethene (BODIPY) derivative with a polyunsaturated butadienyl moiety susceptible to oxidation. In its reduced state, the probe exhibits red fluorescence (excitation/emission maxima: 581/591 nm). Upon oxidation by specific ROS (notably hydroxyl radicals and peroxynitrite), the butadienyl segment is cleaved, resulting in a spectral shift to green fluorescence (excitation/emission maxima: 488/510 nm) (APExBIO). This ratiometric fluorescence enables quantitative assessment of the oxidized/reduced probe ratio, directly reflecting lipid peroxidation levels. Importantly, BODIPY 581/591 C11 shows no fluorescence response to superoxide, nitric oxide, or hydrogen peroxide, conferring high selectivity (paricalcitolcatalog.com). The probe is cell-permeable and can be incorporated into live-cell assays or artificial membrane models.

Evidence & Benchmarks

• BODIPY 581/591 C11 is validated for quantitative lipid peroxidation detection in live MC3T3-E1 osteoblasts using flow cytometry and immunofluorescence (Zhang et al., 2025).
• The probe’s emission shift (591 nm to 510 nm) is proportional to the degree of lipid oxidation in biological membranes (APExBIO).
• Photostability and quantum yield of BODIPY 581/591 C11 enable extended imaging and reproducible quantification in live-cell assays (apexapoptosis.com).
• BODIPY 581/591 C11 does not respond to superoxide, nitric oxide, or hydrogen peroxide, minimizing false positives in oxidative stress assays (paricalcitolcatalog.com).
• Storage at −20°C, protected from light and moisture, preserves probe stability for up to 2 years (APExBIO).

Applications, Limits & Misconceptions

Core Applications

• Real-time measurement of lipid peroxidation in live cells and artificial membranes.
• Evaluation of antioxidant capacity in response to pharmacological or genetic interventions.
• Assessment of ferroptosis and oxidative cell death pathways in cancer and neurodegenerative disease models (Zhang et al., 2025).
• Quantitative ROS signaling studies in metabolic, cardiovascular, and bone research.

Common Pitfalls or Misconceptions

• BODIPY 581/591 C11 does not report on superoxide, nitric oxide, or hydrogen peroxide; using it for these ROS yields false negatives.
• Stock solutions are unstable at room temperature or under light; always prepare fresh and protect from light.
• Long-term storage of probe solutions is not recommended; use immediately after dilution for consistent results.
• High probe concentrations may induce phototoxicity or alter membrane properties; optimize concentrations for each model system.
• Quantitative ratiometric analysis requires calibration and proper instrument settings to avoid artifacts.

This article extends prior guides such as MoleculeProbe by providing updated peer-reviewed evidence and explicit limitations for BODIPY 581/591 C11. For troubleshooting and assay design, see this scenario-based Q&A, which is complemented here by detailed mechanism and benchmarking discussion.

Workflow Integration & Parameters

• Reagent Preparation: Dissolve BODIPY 581/591 C11 solid (MW 504.42, C30H35BF2N2O2) in DMSO or ethanol; final working concentrations typically range from 1–5 μM.
• Sample Loading: Incubate cells or membranes with probe for 15–30 min at 37°C, protected from light.
• Detection: Measure red (excitation 581 nm/emission 591 nm) and green (excitation 488 nm/emission 510 nm) fluorescence using flow cytometry or confocal microscopy.
• Ratiometric Quantification: Calculate the 591/510 nm emission ratio to quantify lipid peroxidation.
• Storage: Store solid probe at −20°C, protected from light and moisture; use solutions immediately after preparation.
• Controls: Include positive (e.g., cumene hydroperoxide) and negative (e.g., antioxidant-treated) controls for assay validation.

BODIPY 581/591 C11 integrates seamlessly into standard live-cell imaging and flow cytometry pipelines (proguanilonline.com), with specific parameters adaptable for model system and instrument configuration.

Conclusion & Outlook

BODIPY 581/591 C11, available from APExBIO (official product page), is a rigorously validated, ratiometric fluorescent probe for the quantitative detection of lipid peroxidation in live cells and model membranes. Its unique emission shift, high photostability, and selectivity for oxygen radicals and peroxynitrite underpin its status as a gold standard for oxidative stress measurement and antioxidant capacity evaluation. Recent studies, such as the inhibition of osteoblast ferroptosis in glucocorticoid-induced osteoporosis (Zhang et al., 2025), demonstrate translational value in disease modeling. For robust, reproducible results, adherence to storage, handling, and calibration best practices is essential. The ongoing expansion of redox biology, ferroptosis research, and antioxidant therapeutic development will continue to rely on precision probes like BODIPY 581/591 C11.